诺和诺德市值蒸发4500亿美元,遭遇六个月来最差单周表现

新浪财经
Feb 07

来源:环球市场播报就在上个月,诺和诺德公司的股价似乎还迎来了转机。分析师们对这家丹麦药企的爆款减肥针剂维格卫的口服版本前景持乐观态度,投资者也似乎已将这家昔日市场宠儿的销售前景疲软因素纳入股价定价。而本周,市场叙事彻底反转。诺和诺德股价暴跌 21%,先是受营收超预期大幅下滑的业绩指引冲击,随后远程医疗企业 Hims & Hers 健康公司又推出了定价更低的维格卫减肥药丸仿制品。尽管周五股价小幅反弹...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10